dave fredrickson, evp oncology business unit, astrazeneca, talks about ovarian cancer commitment
Published 2 years ago • 56 plays • Length 0:44Download video MP4
Download video MP3
Similar videos
-
14:48
business brief: david fredrickson, evp, oncology business unit, astrazeneca
-
4:32
esgo engage and astrazeneca announce ovarian cancer commitment - occ
-
4:51
ovarian cancer panel – introduction
-
6:57
ovarian cancer panel – the future of ovarian cancer care
-
7:50
cure in cancer: dave fredrickson and dr. elizabeth franklin
-
office hours with earth's virology professor livestream 8/07/24 8 pm edt
-
1:00:35
ovarian cancer: current treatments and latest advances
-
27:05
2023 ovarian cancer symposium - professor alison brand
-
13:11
astrazeneca’s dave fredrickson at reuters pharma marketing europe 2020
-
11:35
ovarian cancer panel – signs and symptoms
-
6:02
ovarian cancer panel – early diagnosis & biomarker testing
-
10:10
ovarian cancer panel – impact of the covid-19 pandemic
-
0:43
new normal, same cancer - astrazeneca’s david fredrickson calls on patients to get checkups
-
0:44
risk factors - ovarian cancer answers
-
0:42
dr. zsiros discusses pembrolizumab triplet in recurrent ovarian cancer
-
1:48
ovarcome's founder shares the key symptoms of ovarian cancer
-
0:56
the powell-drescher ovarian cancer research foundation
-
2:22
professor clare scott – outsmarting ovarian cancer | cancer council
-
17:26
professor david bowtell: current & future ovarian cancer treatments
-
1:00
biomarker research in ovarian cancer
-
1:53
esmo oncologypro - presentation by dr. e. smyth
-
1:29
fcl friday september 29th: patients with ovarian cancer